Build your base

Alienum phaedrum torquatos nec eu, vis detraxit periculis ex, nihil expetendis in mei. Mei an pericula euripidis, hinc partem ei est.
Back to top

Elin Haf Davies, PhD

New Horizon / Elin Haf Davies, PhD

Elin Haf Davies, PhD

CEO of Aparito


Elin Haf Davies has 20+ years paediatric drug development experience across clinical, academic and regulatory. Her PhD focused on developing biomarkers and outcome measures of ataxia in children with neuro Lysosomal Storage Disorders. She was also part of the core team at the European Medicine Agency (EMA) responsible for implementing the Paediatric Regulation (EC) No1901/2006 in Europe. Since leaving the EMA, Elin Haf has focused her efforts on supporting innovative study designs, including founding a digital health company to support decentralised clinical trials and digital biomarkers; Aparito.



Oct 29th 11:30AM ET - Panelist Session 5 – Multifaceted Approach to Patient Engagement in Pediatric Clinical Research